IRIS
PASSINO, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 43.980
EU - Europa 28.376
AS - Asia 18.459
SA - Sud America 4.681
AF - Africa 408
OC - Oceania 111
Continente sconosciuto - Info sul continente non disponibili 109
Totale 96.124
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 41.575
SG - Singapore 7.639
RU - Federazione Russa 7.209
GB - Regno Unito 7.055
CN - Cina 4.719
IT - Italia 4.384
BR - Brasile 3.843
VN - Vietnam 2.457
UA - Ucraina 2.301
DE - Germania 2.197
CA - Canada 1.961
DK - Danimarca 1.526
HK - Hong Kong 1.388
SE - Svezia 801
FR - Francia 532
IE - Irlanda 530
FI - Finlandia 512
PL - Polonia 494
IN - India 354
AR - Argentina 331
MX - Messico 330
IL - Israele 266
BD - Bangladesh 264
NL - Olanda 263
TR - Turchia 239
ID - Indonesia 183
EC - Ecuador 173
JP - Giappone 166
ZA - Sudafrica 161
ES - Italia 147
PK - Pakistan 137
IQ - Iraq 132
AT - Austria 108
EU - Europa 106
AU - Australia 78
CO - Colombia 78
IR - Iran 65
KR - Corea 64
VE - Venezuela 61
UZ - Uzbekistan 59
SA - Arabia Saudita 54
MA - Marocco 53
PY - Paraguay 50
AE - Emirati Arabi Uniti 49
LT - Lituania 49
CL - Cile 48
PE - Perù 42
KE - Kenya 41
RO - Romania 38
BE - Belgio 33
NZ - Nuova Zelanda 30
EG - Egitto 29
UY - Uruguay 28
CH - Svizzera 27
SK - Slovacchia (Repubblica Slovacca) 26
TN - Tunisia 26
JO - Giordania 25
CZ - Repubblica Ceca 22
BO - Bolivia 21
DZ - Algeria 21
AZ - Azerbaigian 20
ET - Etiopia 20
CR - Costa Rica 17
KZ - Kazakistan 16
NP - Nepal 16
TW - Taiwan 16
JM - Giamaica 15
MY - Malesia 15
DO - Repubblica Dominicana 14
HN - Honduras 14
PH - Filippine 14
AM - Armenia 11
BY - Bielorussia 11
KG - Kirghizistan 11
PT - Portogallo 11
TH - Thailandia 11
GE - Georgia 10
NI - Nicaragua 10
TT - Trinidad e Tobago 10
AL - Albania 9
BG - Bulgaria 9
GR - Grecia 9
QA - Qatar 9
LV - Lettonia 8
NO - Norvegia 8
OM - Oman 8
PA - Panama 8
PS - Palestinian Territory 8
SN - Senegal 8
CI - Costa d'Avorio 7
GH - Ghana 7
GT - Guatemala 7
HU - Ungheria 7
KW - Kuwait 7
BB - Barbados 6
BH - Bahrain 6
EE - Estonia 6
LB - Libano 6
MD - Moldavia 6
MK - Macedonia 6
Totale 96.017
Salva come PNG Salva come JPEG
Città #
Dallas 7.966
Southend 4.837
Singapore 4.098
Woodbridge 2.674
Beijing 2.331
Chandler 2.319
Ann Arbor 2.295
Houston 2.089
Ashburn 2.034
Fairfield 1.626
San Mateo 1.470
Moscow 1.302
Falls Church 1.263
Hong Kong 1.188
Jacksonville 1.095
Seattle 1.081
Dearborn 1.020
Cambridge 963
Wilmington 886
Ottawa 857
Los Angeles 852
Pisa 630
Ho Chi Minh City 620
Chicago 600
The Dalles 564
Hefei 540
Boardman 525
Stevenage 512
Dublin 506
Portsmouth 502
Dong Ket 483
Warsaw 461
New York 413
Montréal 403
São Paulo 397
Lawrence 385
Hanoi 331
Buffalo 316
Beauharnois 315
Brooklyn 303
Santa Clara 301
Munich 247
Tel Aviv 245
Rome 243
Milan 236
Salt Lake City 226
London 224
Redwood City 174
San Diego 168
Old Bridge 158
Florence 155
Montreal 142
Tokyo 137
Stockholm 136
Rio de Janeiro 132
Frankfurt am Main 131
Poplar 131
Denver 126
Istanbul 122
Orem 122
Chennai 119
Johannesburg 114
Fremont 110
Atlanta 109
Phoenix 109
Tampa 109
Mexico City 105
Elk Grove Village 104
Boston 100
Helsinki 100
Nuremberg 94
Toronto 86
Manchester 74
Haiphong 73
San Francisco 71
Amsterdam 70
Turku 69
Brasília 68
Council Bluffs 68
Belo Horizonte 67
Norwalk 67
Ankara 66
Curitiba 65
Livorno 61
Central District 60
Washington 60
Da Nang 58
Lappeenranta 58
Lucca 57
Tashkent 54
Biên Hòa 53
Porto Alegre 53
Guayaquil 51
Querétaro 51
Quito 51
Bologna 50
Campinas 49
Guangzhou 49
Kansas City 49
Dhaka 48
Totale 59.537
Salva come PNG Salva come JPEG
Nome #
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.600
Value in Healthcare and the Role of the Patient Voice 1.051
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 658
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 551
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 453
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 444
Impact of GFR Estimation Formulas on MECKI Score Performance and Prognostic Accuracy in Heart Failure: The MECKI-RENAL Study 425
E-Health in Tuscany Inner Areas: The PROXIMITY-CARE Approach 413
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 407
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 361
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 345
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 332
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 330
Functional ancient grain bread rich in iron, zinc, flavonoids and alpha lipoic acid attenuates post-ischemic myocardial remodeling in rats 320
Human pathophysiological adaptations to the space environment 317
La neuropatia diabetica 314
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 313
Grapevine microRNAs in an in vitro model of cell line: new potential insight on their role in the setting of human health. 312
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 312
A simple echocardiographic score to rule out cardiac amyloidosis 307
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 298
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 295
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 294
Treating chemoreflex in heart failure: modulation or demolition? 293
Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: some results. 292
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 290
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 290
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 289
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 288
Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin i 288
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases. 287
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 285
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 281
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 281
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 281
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 280
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 280
Adrenergic activation in heart failure: blockade or rebalance? 276
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 276
Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy 274
Evaluation of analytical performance and comparison of clinical results of the new generation method AccuTnI+3 for the measurement of cardiac troponin I using both patients and quality control plasma samples 274
Tuscany Sangiovese Grape juice imparts cardioprotection by regulating gene expression of Cardioprotective C-Type Natriuretic Peptide. 274
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 269
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 269
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 268
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease 268
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 264
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 264
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 262
Prediction of the chemoreflex gain by common clinical variables in heart failure 262
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 261
Bioinformatics analysis of the gene profile of coronary endothelial cells treated with Grapevine microRNAs: an in vitro study 260
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 259
A simple echocardiographic score to rule out cardiac amyloidosis 258
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 258
Natriuretic peptides expression in a murine model of myocardial infarction after Sangiovese grape juice intake. Focus on CNP and ON putative involvement of plant miRNAs in-vitro and in healthy humans 258
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 256
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 255
Acute and persistent effects of a 46-kilometer wilderness trail run at altitude: cardiovascular autonomic modulation and baroreflexes. 254
[Central apneas and cardiovascular diseases] 253
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 253
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE 253
Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: A cardiac MR study 251
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 250
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 250
A longitudinal assessment of chronic care pathways in real-life: self-care and outcomes of chronic heart failure patients in Tuscany 249
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 249
Usefulness of high-sensitive troponin elevation after effort stress to unveil vulnerable myocardium in patients with hart failure 249
Biomarcatori di stabilità della placca aterosclerotica (Rassegna) 248
Evaluation of analytical performance of a novel immunoenzymometric assay for cTnI. 247
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 247
Metabolic exercise data combined with cardiac and kidney indexes: MECKI score. Predictive role in cardiopulmonary exercise testing with low respiratory exchange ratio in heart failure 247
Ancient grain bread rich in iron, zinc, flavonoids and alpha lipoic acid as a novel preoperative functional food for suppressing the progression of cardiovascular remodeling in infarcted male rats 246
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 245
Cardiac biomarker testing in the clinical laboratory:Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. 244
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 243
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 243
Marcatori di rimodellamento e fibrosi cardiaca 242
Influence of Type of Surgery on the Occurrence of Parasympathetic Reinnervation After Cardiac Transplantation 241
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 240
The metabolic exercise test data combined with Cardiac and Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study 240
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 239
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 237
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 237
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 236
Sex-related differences in chronic heart failure 235
Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible? 234
Cardiac light-chain deposition disease relapsing in the transplanted heart 234
How to take arms against central apneas in heart failure 234
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 234
N-terminal proB-type natriuretic peptide (NT-proBNP) is superior to BNP for the detection of eraly/mild forms of heart failure 232
Evaluation of analytical performance and qualità specifications of a novel immunoenzymometric assay for cTnI: comparison with cTnI and cTnT immunoassays 232
Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure 232
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 231
Evaluation of reference change values for a hs-cTnI immunoassay using both plasma samples of healthy subjects and patients and quality control samples 231
Renal denervation in resistant arterial hypertension: Effects on neurohormonal activation and cardiac natriuretic peptides 230
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 230
Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy 229
B-type natriuretic peptide secretion following scuba diving 228
Prognostic Value of Indeterminable Anaerobic Threshold in Heart Failure. 226
Totale 30.127
Salva come PNG Salva come JPEG
Categoria #
all - tutte 509.788
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 509.788
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216.328 0 0 0 0 0 1.457 917 604 630 623 744 1.353
2021/20226.927 477 1.282 379 663 153 119 764 1.269 561 670 114 476
2022/20235.337 402 312 276 790 779 826 53 432 917 106 244 200
2023/20243.247 292 112 528 227 210 337 303 190 191 167 168 522
2024/202521.093 192 234 1.198 489 999 1.286 2.826 5.165 1.700 1.412 3.316 2.276
2025/202629.951 2.676 8.082 5.678 6.166 5.331 2.018 0 0 0 0 0 0
Totale 96.761